CNA trades 4.9% above Wall Street's consensus target of $45.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CNA achieves its forward estimates and maintains a stable P/E multiple of 12.4x. This scenario reflects the blended consensus of 7 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 8, 2026, CNA Financial Corporation (CNA) has a Wall Street consensus price target of $45.00, based on estimates from 7 covering analysts. With the stock currently trading at $47.32, this represents a potential downside of -4.9%. The company has a market capitalization of $12.80B.
Analyst price targets range from a low of $45.00 to a high of $45.00, representing a 0% spread in expectations. The median target of $45.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 2 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 1 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, CNA trades at a trailing P/E of 10.1x and forward P/E of 12.4x. The forward PEG ratio of 0.94 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow -8.9% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $49.33, with bear and bull scenarios of $31.07 and $64.99 respectively. Model confidence stands at 44/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 TRVThe Travelers Companies, Inc. | $82.4B | $395.20 | $356.18 | -9.9% | Hold | 10.8x | 44 |
 HIGThe Hartford Insurance Group, Inc. | $36.7B | $133.99 | $145.40 | +8.5% | Buy | 10.3x | 42 |
 CBChubb Limited | $141.6B | $365.02 | $355.91 | -2.5% | Buy | 12.5x | 44 |
 WRBW. R. Berkley Corporation | $28.0B | $75.23 | $70.56 | -6.2% | Hold | 15.2x | 30 |
 MKLMarkel Corporation | $24.0B | $1939.04 | $1708.33 | -11.9% | Hold | 18.7x | 15 |
 CINFCincinnati Financial Corporation | $28.5B | $185.48 | $198.00 | +6.8% | Hold | 20.2x | 17 |
 AIGAmerican International Group, Inc. | $41.2B | $77.75 | $87.14 | +12.1% | Hold | 9.6x | 41 |
 ACGLArch Capital Group Ltd. | $37.5B | $107.28 | $112.50 | +4.9% | Hold | 10.6x | 34 |
 RNRRenaissanceRe Holdings Ltd. | $14.4B | $347.35 | $338.13 | -2.7% | Hold | 7.0x | 28 |
 SKWDSkyward Specialty Insurance Group, Inc. | $2.4B | $60.35 | $66.33 | +9.9% | Buy | 12.0x | 12 |
Quick answers to the most common questions about buying CNA stock.
Wall Street's consensus price target for CNA is $45, -4.9% from its current price of $47.32. The below-market target from 7 analysts suggests limited near-term appreciation.
CNA has a consensus rating of "Hold" based on 7 Wall Street analysts. The rating breakdown is mixed, with 4 Hold ratings making up the largest segment. The consensus 12-month price target of $45 implies -4.9% downside from current levels.
With a forward P/E of 12.3657x, CNA trades at a relatively low valuation. The consensus target of $45 implies -4.9% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $45 for CNA, while the most conservative target is $45. The consensus of $45 represents the median expectation. Our quantitative valuation model projects a bull case target of $65 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CNA is moderately covered, with 7 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 4 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CNA stock forecast based on 7 Wall Street analysts shows a consensus price target of $45, with estimates ranging from $45 (bear case) to $45 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $49, with bear/bull scenarios of $31/$65.
Our quantitative valuation model calculates CNA's fair value at $49 (base case), with a bear case of $31 and bull case of $65. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 44/100.
CNA trades at a forward P/E ratio of 12.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 10.1x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on CNA, with 1 Sell ratings and a price target of $45 (-4.9% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CNA analyst price targets range from $45 to $45, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $45 consensus represents the middle ground. Our model's $31-$65 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.